Bibliography
- Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49
- Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-14
- Rosier PF, de la Rosette JJ, Wijkstra H, et al. Is detrusor instability in elderly males related to the grade of obstruction? Neurourol Urodyn 1995;14:625-33
- Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006;49:651-8
- Jolleys JV, Donovan JL, Nanchahal K, et al. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994;74:551-5
- Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001;166:563-8
- Peters TJ, Donovan JL, Kay HE, et al. The International Continence Society “Benign Prostatic Hyperplasia” study: the bothersomeness of urinary symptoms. J Urol 1997;157:885-9
- Turner WH, Brading AF. Smooth muscle of the bladder in the normal and diseased state: pathophysiology, diagnosis and treatment. Pharmacol Ther 1997;72:77-110
- Gosling JA, Kung LS, Dixon LS, et al. Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction. J Urol 2000;163:1349-56
- Anderson KE, Yoshida M. Antimuscarinics and the overactive detrusor: which is the main mechanism of action? Eur Urol 2003;43:1-5
- Anderson KE. Storage and voiding symptoms: pathophysiology aspects. Urology 2003;62:3-10
- Hirayama A, Fujimoto K, Matsumoto Y, et al. Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology 2003;62:909-13
- Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 2006;98:503-7
- Nishimatsu H, Homma Y, Kawabe K, et al. Efficacy of treatment with propiverine hydrochloride in patients on lower urinary tract function: BUP-4 tablets special study group II. Jpn J Urol Surg 1999;12:857-67
- Abrams P, Kaplan S, Millard R. Safety of tolterodine in men with bladder outlet obstruction (BOO) and symptomatic detrusor overactivity. Eur Urol Suppl 2002;1:132
- Abrams P, Kaplan S, De Koning Gans HJ, Millard R. Safety and tolerability of tolderodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 2006;175:999-1004
- Kaplan SA, Walmsley K, Te AE. Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers. J Urol (Suppl) 2004;171:[abstract No 917]
- Kaplan SA, Walmsley K, Te AE. Tolderodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 2005;174:2273-6
- Saito H, Yamada T, Oshima H, et al. A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence. Jpn J Urol Surg 1999;8:525-36
- Athanasopoulos A, Gyftopoulos K, Giannitsas K, et al. Combination treatment with an a-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized controlled study. J Urol 2003;169:2253-6
- Athanasopoulos A, Gyftopoulos K, Giannitsas K, et al. Combination treatment with an a-blocker plus an anticholinergic improves quality of life in patients with bladder outlet obstruction: a prospective, randomized, controlled study. Neur Urodyn 2002;21:308-9
- Okada H, Shirakawa T, Muto S, et al. Propiverine hydrochloride relieves irritative symptoms of benign prostatic hyperplasia. J Urol (Suppl) 2004;171:357
- Suzuki Y, Takasaka S, Kishimoto K, et al. Combination treatment with an alpha1-blocker plus an anticholinergic for the patients with suspected bladder outlet obstruction (BOO) concomitant with over-active bladder (OAB). Proceedings of the International Continence Society [abstract 471]. 34th annual meeting with the International Urogynecological Association. Paris, France; 2004
- Lim E, Chia SJ. Combination therapy using alpha-blocker and antimuscarinic drugs in men with lower urinary tract symptoms suggestive of bladder outlet obstruction and an overactive bladder: is it safe and efficacious? Proceedings of the International Continence Society [abstract 205]. 35th annual meeting; 2005
- Lee JY, Kim HW, Lee SJ, et al. Comparison of doxazosin with or without tolderodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 2004;94:817-20
- Lee KS, Choo MS, Kim DY, et al. Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign obstruction: a prospective, randomized, controlled multicenter study. J Urol 2005;174:1334-8
- Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolderodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 2006;296:2319-28
- Xia H, Li HZ, Yang Y, et al. Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH. Zhonghua Yi Xue Za Zhi 2007;87:1590-3
- Staskin DR, Rosenberg MT, Dahl NV, et al. Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions. Int J Clin Pract 2008;62:27-38
- Novara G, Galfano A, Ficarra V, et al. Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systematic review. Eur Urol 2006;50:675-83
- Blake-James T, Rashidian A, Ikeda Y, Emberton M. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int 2006;99:85-96
- Meigs JB, Barry MJ, Giovannucci E, et al. Incidence rates and risk factors for acute urinary retention: the health professionals follow-up study. J Urol 1999;162:376-82